230 related articles for article (PubMed ID: 28464886)
41. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
42. Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis.
An Q; Pacyna-Gengelbach M; Schlüns K; Deutschmann N; Guo S; Gao Y; Zhang J; Cheng S; Petersen I
Int J Cancer; 2003 Jan; 103(2):194-204. PubMed ID: 12455033
[TBL] [Abstract][Full Text] [Related]
43. Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan.
Wu X; Wen CP; Ye Y; Tsai M; Wen C; Roth JA; Pu X; Chow WH; Huff C; Cunningham S; Huang M; Wu S; Tsao CK; Gu J; Lippman SM
Sci Rep; 2016 Nov; 6():36482. PubMed ID: 27805040
[TBL] [Abstract][Full Text] [Related]
44. Early Detection of Lung Cancer with Meso Tetra (4-Carboxyphenyl) Porphyrin-Labeled Sputum.
Patriquin L; Merrick DT; Hill D; Holcomb RG; Lemieux ME; Bennett G; Karia B; Rebel VI; Bauer T
J Thorac Oncol; 2015 Sep; 10(9):1311-1318. PubMed ID: 26200451
[TBL] [Abstract][Full Text] [Related]
45. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
46. Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.
Kahn N; Meister M; Eberhardt R; Muley T; Schnabel PA; Bender C; Johannes M; Keitel D; Sültmann H; Herth FJ; Kuner R
J Thorac Oncol; 2012 Jun; 7(6):1001-8. PubMed ID: 22588153
[TBL] [Abstract][Full Text] [Related]
47. Detection of lung cancer using weighted digital analysis of breath biomarkers.
Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P; Wai J
Clin Chim Acta; 2008 Jul; 393(2):76-84. PubMed ID: 18420034
[TBL] [Abstract][Full Text] [Related]
48. Fusion of Quantitative Image and Genomic Biomarkers to Improve Prognosis Assessment of Early Stage Lung Cancer Patients.
Emaminejad N; Qian W; Guan Y; Tan M; Qiu Y; Liu H; Zheng B
IEEE Trans Biomed Eng; 2016 May; 63(5):1034-1043. PubMed ID: 26390440
[TBL] [Abstract][Full Text] [Related]
49. Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer.
Zhou D; Tang W; Liu X; An HX; Zhang Y
Oncotarget; 2017 Jul; 8(27):43978-43989. PubMed ID: 28410204
[TBL] [Abstract][Full Text] [Related]
50. Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.
Zeng GQ; Zhang PF; Deng X; Yu FL; Li C; Xu Y; Yi H; Li MY; Hu R; Zuo JH; Li XH; Wan XX; Qu JQ; He QY; Li JH; Ye X; Chen Y; Li JY; Xiao ZQ
Mol Cell Proteomics; 2012 Jun; 11(6):M111.013946. PubMed ID: 22298307
[TBL] [Abstract][Full Text] [Related]
51. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.
Liu YZ; Jiang YY; Wang BS; Hao JJ; Shang L; Zhang TT; Cao J; Xu X; Zhan QM; Wang MR
Cancer Cytopathol; 2014 Nov; 122(11):833-41. PubMed ID: 25045014
[TBL] [Abstract][Full Text] [Related]
52. miR-Test: a blood test for lung cancer early detection.
Montani F; Marzi MJ; Dezi F; Dama E; Carletti RM; Bonizzi G; Bertolotti R; Bellomi M; Rampinelli C; Maisonneuve P; Spaggiari L; Veronesi G; Nicassio F; Di Fiore PP; Bianchi F
J Natl Cancer Inst; 2015 Jun; 107(6):djv063. PubMed ID: 25794889
[TBL] [Abstract][Full Text] [Related]
53. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
[TBL] [Abstract][Full Text] [Related]
54. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
Giesing M; Suchy B; Driesel G; Molitor D
BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
[TBL] [Abstract][Full Text] [Related]
55. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
[TBL] [Abstract][Full Text] [Related]
56. Improving lung cancer prognosis assessment by incorporating synthetic minority oversampling technique and score fusion method.
Yan S; Qian W; Guan Y; Zheng B
Med Phys; 2016 Jun; 43(6):2694-2703. PubMed ID: 27277016
[TBL] [Abstract][Full Text] [Related]
57. CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions.
Crawford EL; Blomquist T; Mullins DN; Yoon Y; Hernandez DR; Al-Bagdhadi M; Ruiz J; Hammersley J; Willey JC
Carcinogenesis; 2007 Dec; 28(12):2552-9. PubMed ID: 17893230
[TBL] [Abstract][Full Text] [Related]
58. Linking the generation of DNA adducts to lung cancer.
Ceppi M; Munnia A; Cellai F; Bruzzone M; Peluso MEM
Toxicology; 2017 Sep; 390():160-166. PubMed ID: 28928033
[TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings.
Kawahara A; Fukumitsu C; Taira T; Abe H; Takase Y; Murata K; Yamaguchi T; Azuma K; Ishii H; Takamori S; Akiba J; Hoshino T; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):620-8. PubMed ID: 26235264
[TBL] [Abstract][Full Text] [Related]
60. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
